Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review voucher
Biotech
Acadia makes $100M profit from $150M pediatric voucher sale
Acadia has bagged $150 million from the sale of a priority review voucher—although the biotech will only be able to keep two-thirds of the windfall.
James Waldron
Nov 6, 2024 9:36am
Valneva sells priority review voucher for $103M, R&D to benefit
Feb 5, 2024 9:15am
Novartis buys priority review voucher from Pharming for $21M
Jun 1, 2023 7:12am
Marinus sells priority review voucher to Novo Nordisk for $110M
Jul 14, 2022 10:50am
BridgeBio adds another $110M to coffers with voucher sale
May 13, 2022 9:45am
